Anti-Tumour Necrosis Factor Therapy for Paediatric Crohn's Disease: Improved Benefits Through Treatment Optimisation, Deeper Understanding of Its Risks, and Reduced Costs due to Biosimilar Availability

Paediatric Drugs
Martinus A CozijnsenLissy de Ridder

Abstract

Antibodies directed to tumour necrosis factor-α (TNF-α) are very effective in treating paediatric Crohn's disease (CD). Over the last few years, research has provided important new insights into how to optimise this treatment's effectiveness. Research on predictors for anti-TNF treatment responsiveness has revealed potential markers, but data on their accuracy in paediatric CD patients are lagging behind. Also, new evidence has become available on the safety profile of anti-TNF antibodies that suggests the assumed increased malignancy risk seen in patients on anti-TNF and thiopurine combination treatment may be linked more to thiopurine use and not to anti-TNF treatment. In addition, the early results of CT-P13, an infliximab biosimilar, in CD patients confirm the expected similarity with its originator. Thus, the effectiveness of anti-TNF antibody treatment is slowly improving, its malignancy risk is lower than assumed, and its costs are reduced by the introduction of equally effective biosimilars. Together, these trends allow for a more prominent role for anti-TNF antibodies in future treatment of paediatric CD.

References

Nov 30, 2000·The American Journal of Gastroenterology·S KugathasanD G Binion
Apr 30, 2003·Journal of Pediatric Gastroenterology and Nutrition·Jean-Pierre CezardOlivier Goulet
Aug 28, 2003·Alimentary Pharmacology & Therapeutics·P LionettiA Barabino
Oct 9, 2004·Inflammatory Bowel Diseases·Séverine VermeirePaul Rutgeerts
Nov 13, 2004·The New England Journal of Medicine·Peter J MannonUNKNOWN Anti-IL-12 Crohn's Disease Study Group
Sep 7, 2005·Gastroenterology·Stefan SchreiberUNKNOWN CDP870 Crohn's Disease Study Group
Dec 25, 2007·Pharmacology & Therapeutics·Daniel TraceyPaul P Tak
Aug 30, 2008·Gastroenterology·Johan Van LimbergenDavid C Wilson
Nov 22, 2008·Inflammatory Bowel Diseases·Frank M RuemmeleUNKNOWN Groupe Francophone d'Hépatologie, Gastroentérologie et Nutrition Pédiatrique
Jun 30, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Corey A SiegelBruce E Sands
Jun 30, 2009·Journal of Pediatric Gastroenterology and Nutrition·Wallace CrandallRobert N Baldassano
Aug 4, 2009·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Sho-ichiro FujishimaMitsunori Yamakawa
Oct 17, 2009·Inflammatory Bowel Diseases·Bénédicte PigneurJacques Cosnes
Apr 16, 2010·The New England Journal of Medicine·Jean Frédéric ColombelUNKNOWN SONIC Study Group
Jun 3, 2010·World Journal of Gastroenterology : WJG·Severine VermeirePaul Rutgeerts
Jun 22, 2010·Inflammatory Bowel Diseases·Eric I BenchimolAnne M Griffiths
Sep 18, 2010·Inflammatory Bowel Diseases·Ingrid ArijsPaul Rutgeerts
Oct 5, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·David S KotlyarGary R Lichtenstein
Jun 1, 2009·Journal of Crohn's & Colitis·J F RahierUNKNOWN European Crohn's and Colitis Organisation (ECCO)
Sep 22, 2011·Inflammatory Bowel Diseases·Anne Christine W VosDaniel W Hommes
May 9, 2012·Gastroenterology·Jeffrey S HyamsAndreas Lazar
May 16, 2012·Journal of Pediatric Gastroenterology and Nutrition·Gigi Veereman-WautersUNKNOWN ESPGHAN IBD Porto Group
Dec 4, 2012·Journal of Crohn's & Colitis·Martin BortlikMilan Lukas
Mar 13, 2013·Scandinavian Journal of Gastroenterology·Clas-Göran af BjörkestenMartti Färkkilä
Jan 1, 2014·Inflammatory Bowel Diseases·Lissy de RidderUNKNOWN Porto IBD Working Group of ESPGHAN
Jun 10, 2014·Journal of Crohn's & Colitis·F M RuemmeleUNKNOWN European Society of Pediatric Gastroenterology, Hepatology and Nutrition
Oct 24, 2014·World Journal of Gastroenterology : WJG·Rong FanYong-Hua Tang

❮ Previous
Next ❯

Citations

Oct 27, 2018·Current Clinical Pharmacology·Efraín EstebanEdwin Jáuregui
Jun 24, 2021·Digestive Diseases and Sciences·Aurélie GrandmouginValérie Laurent

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies

Clinical Trials Mentioned

NCT00606346

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.